Dr. Andrew J. Levada has been at The Eye Care Group since 1983 as a pediatric ophthalmologist with a special interest in adult eye muscle disorder. Prior to joining the practice, Dr. Levada graduated from Princeton University with an A.B. in Physics and from the Harvard Medical School with an M.D. degree. He completed his residency in Ophthalmology and his Fellowship at the world-renowned Bascom Palmer Eye Institute.
As a former president of both the Connecticut Society of Eye Physicians and Prevent Blindness Connecticut, Dr. Levada is also a Fellow of the American Board of Ophthalmology and the American College of Surgeons and has operated at St. Mary's Hospital and Waterbury Hospital Health Center as Section Chief of Ophthalmology. In addition, he is a Diplomat of the American Board of Internal Medicine. Dr. Levada is also a member of the American Association for Pediatric Ophthalmology and Strabismus, the Connecticut Society of Eye Physicians, and the American Academy of Ophthalmology.
Dr. Levada also dedicates much of his time to Yale University in the Department of Ophthalmology and Visual Science as an Associate Clinical Professor of Ophthalmology, as well as, training residents in the field of pediatric ophthalmology.
While investigating Botox during its developing stages in 1990, Dr. Levada's studies led to the authorization of Botox to be used within the medical field of eye care to treat eye muscle diseases. As a result, Dr. Levada became the pioneer investigator to use Botox in New England giving way to popular uses of relaxing muscles in many areas of medicine. In view of this fact, he has been a founding member of the Pediatric Eye Disease Investigator Group and maintains his level of participation as a Principal Investigator in several multicenter trials to fund the progression of high-tech strabismus and lazy eye treatment through the National Institute of Health.